| 0.11% |
| 4 | STATE STREET CORP | 26.3M | $2.38B | +0.1% | 4.571% | 0.04% |
| 5 | JPMORGAN CHASE & CO | 22.8M | $2.08B | +4.8% | 3.957% | 0.11% |
| 6 | WELLINGTON MANAGEMENT GROUP LLP | 16.8M | $1.52B | -23.5% | 2.923% | 0.26% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 15.4M | $1.39B | +17.5% | 2.681% | 0.07% |
| 8 | Bank of New York Mellon Corp | 14.1M | $1.27B | -15.8% | 2.446% | 0.21% |
| 9 | DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt | 13.0M | $1.18B | +1.5% | 2.258% | 0.90% |
| 10 | Ninety One UK Ltd | 12.3M | $1.12B | -0.5% | 2.143% | 2.50% |
| 11 | Aristotle Capital Management, LLC | 8.7M | $783.9M | — | 1.505% | 1.64% |
| 12 | FMR LLC | 8.4M | $763.1M | -41.8% | 1.465% | 0.03% |
| 13 | NORGES BANK | 8.4M | $757.5M | — | 1.454% | 0.08% |
| 14 | ALLIANCEBERNSTEIN L.P. | 8.7M | $693.5M | +149.8% | 1.504% | 0.23% |
| 15 | BROWN ADVISORY INC | 7.4M | $666.3M | +4.8% | 1.279% | 1.03% |
| 16 | BANK OF AMERICA CORP /DE/ | 6.7M | $605.4M | +72.3% | 1.162% | 0.04% |
| 17 | Artisan Partners Limited Partnership | 6.6M | $599.4M | +27.4% | 1.151% | 0.95% |
| 18 | MORGAN STANLEY | 6.3M | $573.5M | -10.2% | 1.101% | 0.03% |
| 19 | DEUTSCHE BANK AG\ | 5.7M | $516.6M | -7.7% | 0.992% | 0.15% |
| 20 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 5.7M | $513.6M | +200.3% | 0.986% | 0.23% |
| 21 | NORTHERN TRUST CORP | 5.7M | $513.0M | -2.6% | 0.985% | 0.06% |
| 22 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME | 5.5M | $496.5M | +0.6% | 0.953% | 0.09% |
| 23 | WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST | 4.8M | $434.2M | 0.0% | 0.834% | 4.82% |
| 24 | GOLDMAN SACHS GROUP INC | 4.5M | $411.5M | -11.5% | 0.790% | 0.04% |
| 25 | Legal & General Group Plc | 4.3M | $389.1M | -3.3% | 0.747% | 0.08% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in EW — a direct measure of their conviction.
| 83.93% |
| 1.66 pp |
| $35.05B |
| 0.6% |
| Q4 2024 | 1,171 | +2.3% | 85.59% | +2.28 pp | $35.28B | +16% |
| Q3 2024 | 1,145 | — | 83.31% | — | $30.31B | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
138 institutions opened new positions in EW during Q2 2026, while 99 fully exited. 968 added to existing positions and 180 trimmed.
EW institutional ownership rose by 3.01 percentage points quarter-over-quarter, with a net change of +49 holders.
The top 10 institutions account for 47.7% of all reported 13F value in EW, and the top 25 account for 66.5%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Edwards Lifesciences Corporation (EW) Institutional Ownership